Literature DB >> 17723877

Testosterone precursors: use and abuse in pediatric athletes.

Troy M Smurawa1, Joseph A Congeni.   

Abstract

The dietary supplements androstenedione, dehydroepiandrosterone, and androstenediol are precursors in the endogenous production of testosterone. The efficacy and safety of these prohormones are not well established but are promoted to have the same androgenic effects on building muscle mass and strength as anabolic-androgenic steroids. Studies have demonstrated repeatedly that acute and long-term administration of these oral testosterone precursors does not effectively increase serum testosterone levels and fails to produce any significant changes in lean body mass, muscle strength, or performance improvement compared with placebo. The Anabolic Steroid Control Act of 2004 lists androstenedione as a schedule III controlled substance, and it is regulated by the U.S. Food and Drug Administration. Testosterone precursors are banned by most major sports organizations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723877     DOI: 10.1016/j.pcl.2007.05.002

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

Review 1.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

Review 2.  Anabolic Androgenic Steroids: Searching New Molecular Biomarkers.

Authors:  Francesco Sessa; Monica Salerno; Giulio Di Mizio; Giuseppe Bertozzi; Giovanni Messina; Benedetta Tomaiuolo; Daniela Pisanelli; Francesca Maglietta; Pietrantonio Ricci; Cristoforo Pomara
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

3.  Alteration of Testosterone Levels Changes Brain Wave Activity Patterns and Induces Aggressive Behavior in Rats.

Authors:  Daniel Pantoja Estumano; Luan Oliveira Ferreira; Paulo Augusto Lima Bezerra; Maria Clara Pinheiro da Silva; Giovanna Coutinho Jardim; George Francisco Souza Santos; Kayo Silva Gustavo; Bruna Gerrits Mattos; Jorge Amando Batista Ramos; Vanessa Jóia de Mello; Edmar Tavares da Costa; Dielly Catrina Favacho Lopes; Moisés Hamoy
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-24       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.